Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

COGT Cogent Biosciences Inc

7,895

0,295 (3,88%)

Zuletzt aktualisiert: 20:06:45

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Cogent Biosciences (NASDAQ:COGT)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Cogent Biosciences Charts.

Cogent Biosciences (NASDAQ:COGT)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Cogent Biosciences Charts.

News Cogent Biosciences Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 7 Mai 2024 (2 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 7 Mai 2024 (2 Tage vor) • Edgar (US Regulatory)

Cogent Biosciences Reports First Quarter 2024 Financial Results
Dienstag 7 Mai 2024 (2 Tage vor) • GlobeNewswire Inc.

Cogent Biosciences Presents Data Highlighting Potential Best-in-Class Potency and Selectivity of Novel, EGFR Sparing, CNS-Penetrant ErbB2 Inhibitor
Dienstag 9 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Montag 26 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Montag 26 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 26 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Montag 26 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis
Donnerstag 22 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Samstag 17 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 17 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Cogent Biosciences Inc News-Artikel

Health Care Select Sector

Gold vs US Dollar

JP Morgan Chase

Deutsche Telekom

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen